Postoperative Analgesia in Laparoscopic Abdominal Surgery After Exparel Via TAP or Local Infiltration

• Status: Unknown status
• Trial end date: 2020-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates differences in how administering liposomal bupivacaine via two different methods affects postoperative pain control in laparoscopic abdominal surgery patients. Half the participants will receive liposomal bupivacaine via a transverses abdominis plane block while the other half will receive liposomal bupivacaine via local infiltration.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Washington
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• Patients scheduled for elective laparoscopic colorectal surgery at UWMC requiring inpatient stay

Exclusion Criteria:

• Patients on chronic pain mediations equaling or exceeding > 25 morphine daily equivalents

• Patients allergic to bupivacaine

• Patients with ASA status IV, V, or VI

• Patients unable to consent

• Patients that are pregnant

• Patients that are incarcerated

• Patients receiving procedures in addition to laparoscopic colorectal procedure

• Patients on systemic anticoagulation precluding them from regional blocks